Pharmasum Therapeutics

Pharmasum Therapeutics

Pre-clinical
Oslo, NorwayFounded 2015pharmasum.com

Dementia is a group of neurodegenerative diseases leading to gradual loss of brain function – such as memory, cognition and daily activities. Dementia is one of the largest unmet healthcare challenges of today. Pharmasum Therapeutics is developing a drug representing a unique innovation in a global market, serving an extremely high unmet medical need.

Founded
2015
Focus
Small Molecules

About

Dementia is a group of neurodegenerative diseases leading to gradual loss of brain function – such as memory, cognition and daily activities. Dementia is one of the largest unmet healthcare challenges of today. Pharmasum Therapeutics is developing a drug representing a unique innovation in a global market, serving an extremely high unmet medical need.

Funding History

2

Total raised: $3.3M

Grant$500KNorwegian Research CouncilMar 15, 2022
Seed$2.8MSarsia Seed ManagementSep 15, 2021

Company Info

TypePrivate
Founded2015
LocationOslo, Norway
StagePre-clinical
SIMILAR COMPANIES
Algipharma
Algipharma
Phase 1 · Bergen
Bio-Me
Bio-Me
Pre-clinical · Oslo
CardiNor
CardiNor
Pre-clinical · Oslo
Gentian USA
Gentian USA
Pre-clinical · Moss
Hemispherian
Hemispherian
Phase 1 · Oslo
Is this your company?

Claim your profile to update information, add pipeline data, and connect with investors.

Claim profile